WAYNE, Pa., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX), a leading global provider of medical technologies, today announced the first patient enrolled in the latest Barrigel™ rectal ...
BETHLEHEM, Pa., Nov. 7, 2025 /PRNewswire/ -- Following publication of BioProtect's pivotal randomized trial in the International Journal of Radiation Oncology, Biology, Physics (Red Journal) and ...
A world-first study shows stabilised hyaluronic acid gel can safely protect the rectum during radiation therapy for ...
Innovative hyaluronic acid technology delivers enhanced control and precision, significantly lowering the risk of rectal toxicity during prostate radiation treatment. 1-4 Hyaluronic acid is a ...
Real-world comparison of prostate-specific antigen (PSA) response among patients with metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide (APA) or enzalutamide (ENZ). This ...
• Highlights include new safety and efficacy data of Barrigel ™ rectal spacer, the first and only sculptable rectal spacer 1-3 • Teleflex to host Barrigel™ Educational Symposium featuring a physician ...
A world-first study led by Austin Health's clinician-researchers has demonstrated the feasibility and safety of using stabilized hyaluronic acid (sHA) gel as a rectal spacer during radiation treatment ...
Prostate cancer is the second most common cancer for American men, yet receiving a diagnosis can feel unexpected. [1] While some people experience symptoms like increased frequency of difficulty ...
Initial cases have now been performed in Japan. WAYNE, Pa., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results